PHARMACEUTICAL COMPOSITION CONSISTING OF A BETALACTAM ANTIBIOTIC IN FIXED DOSE COMBINATION WITH A BETAACTAMASE INHIBITOR AND ADDITIONALLY A NARROW SPECTRUM ANTIBIOTIC FOR ENHANCED SPECTRUM OF ACTIVITITY.

摘要

a) Enhanced bioavailability and dosage schedule. b) Enhanced spectrum of activity of the β-lactam Antibotics, preferably, Ampicillin, Amoxycillin and Cefixime. c) Enhanced stability of β-lactam Antibotics to β-lactamase producing organisms.